logo

Myovant Sciences Ltd (MYOV)



Trade MYOV now with
  Date
  Headline
5/9/2022 8:32:21 AM Myovant, Accord Healthcare Enter License Deal To Commercialize ORGOVYX For Hormone-Sensitive Prostate Cancer In Europe
5/6/2022 7:40:51 AM Myovant, Pfizer: FDA Extends Review Of Myfembree In Endometriosis To August 6, 2022
4/12/2022 1:06:08 AM Myovant Sciences And Pfizer Provide Update On MYFEMBREE SNDA
2/10/2022 9:06:05 AM Sumitomo , Sumitovant Initiate Phase 1 Study On New Drug Candidate For Carbapenem-Resistant Bacterial Infections
7/20/2021 2:13:39 AM Myovant Sciences: European Commission Approves Marketing Authorization Application For RYEQO
5/11/2021 7:14:34 AM Myovant Q4 Loss/Shr $0.89 Vs Loss $0.73 Last Year
4/12/2021 7:01:57 AM Myovant, Pfizer: First Participant Dosed In Phase 3 SERENE Study
4/5/2021 7:07:52 AM Myovant Sciences Appoints Lauren Merendino As Chief Commercial Officer
3/24/2021 6:39:10 AM Myovant Sciences, Pfizer Announce Positive Data From Phase 3 LIBERTY Randomized Withdrawal Study